Assessment of the relationship between methylenetetrahydrofolate reductase polymorphism and acute lymphoblastic leukemia: Evidence from an updated meta-analysis.

Rim Frikha

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

Thus, C677T polymorphism may be a promising acute lymphoblastic leukemia biomarker, but they should be interpreted with caution considering other factors such as folic acid intake, gene-gene and gene-environment interactions.

Keyphrases

acute lymphoblastic leukemia
systematic review
copy number
genome wide
genome wide identification
allogeneic hematopoietic stem cell transplantation
randomized controlled trial
gene expression
dna methylation
meta analyses
weight loss